# LGNYZ (Ligand Pharmaceuticals Incorporated) - SEC EDGAR Financial Statements

> Ligand Pharmaceuticals Incorporated reported $253.8M in revenue and net income of $51.46M for the trailing twelve months ended September 30, 2026 (down 31.8% year over year), with a 10.1% operating margin.

- Canonical: https://convexityos.com/fundamentals/LGNYZ
- Markdown: https://convexityos.com/fundamentals/LGNYZ.md
- SEC CIK: 0000886163
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:14 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000886163&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $253.8M | -31.8% YoY |
| Operating Income | TTM | $25.52M | 10.1% margin |
| Net Income | TTM | $51.46M | 20.3% net margin |
| Diluted EPS | TTM | $2.58 | Split-adjusted |
| Free Cash Flow | TTM | $90.63M | 35.7% FCF margin |
| Cash & ST Investments | Sep 30, 2026 | $447.4M | Total debt: $1.15B |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $268.1M | $167.1M | $131.3M | $196.2M | $241.5M | $163.6M | $120.3M | $251.5M | $141.1M | $109.0M |
| Cost of Revenue | -- | -- | -- | -- | -- | -- | -- | $6.34M | $5.37M | $5.57M |
| **Gross Profit** | -- | -- | -- | -- | -- | -- | -- | $245.1M | $135.7M | $103.4M |
| Research & Development | $81.18M | $21.43M | $24.54M | $36.08M | $32.10M | $40.50M | $55.91M | $27.86M | $26.89M | $21.22M |
| **Operating Income** | $41.00M | -$22.61M | $11.94M | $3.04M | $103.9M | $37.50M | $807.1M | $163.7M | $68.08M | $43.88M |
| **EBITDA** | $74.78M | $12.63M | $48.46M | $54.57M | $154.9M | $63.19M | $825.4M | $176.5M | $79.03M | $55.17M |
| Interest Income | $13.66M | $8.05M | $7.71M | $2.05M | $886K | $8.08M | $28.43M | $14.00M | $2.06M | -- |
| Interest Expense | $4.71M | $3.04M | $656K | $1.80M | $19.62M | $27.41M | $35.74M | $48.28M | $13.46M | $12.84M |
| Income Before Tax | $159.0M | $2.52M | $63.66M | $36.01M | $72.20M | $1.29M | $796.6M | $173.3M | $57.23M | $7.96M |
| Income Tax Expense | $34.51M | $6.55M | $9.84M | $41.23M | -$4.15M | -$5.31M | $167.3M | $30.01M | $44.67M | $10.33M |
| **Net Income** | $124.5M | -$4.03M | $52.15M | -$33.36M | $57.14M | -$2.98M | $629.3M | $143.3M | $12.56M | -$1.64M |
| Basic EPS | $6.44 | -$0.22 | $3.02 | -$1.98 | $3.44 | -$0.18 | $33.13 | $6.77 | $0.60 | -$0.08 |
| **Diluted EPS** | $6.13 | -$0.22 | $2.94 | -$1.98 | $3.31 | -$0.18 | $31.85 | $5.96 | $0.53 | -$0.08 |
| Basic Shares Outstanding | 19.3M | 18.3M | 17.3M | 16.9M | 16.6M | 16.2M | 19.0M | 21.2M | 21.0M | 20.8M |
| Diluted Shares Outstanding | 20.3M | 18.3M | 17.8M | 16.9M | 17.2M | 16.8M | 19.8M | 24.1M | 23.5M | 20.8M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $78.75M | $63.69M | $51.72M | $59.67M | $115.5M | $47.63M | $45.33M | $42.81M |
| Research & Development | $2.77M | $14.67M | $2.15M | $3.51M | $21.02M | $6.57M | $50.09M | $4.42M |
| **Operating Income** | -$15.76M | $8.59M | $17.37M | $15.32M | $55.39M | $8.44M | -$36.22M | -$9.64M |
| **EBITDA** | -$5.43M | $16.81M | $25.58M | $23.53M | $63.66M | $16.97M | -$27.45M | -$1.01M |
| Interest Income | $5.49M | $7.30M | $6.66M | $6.39M | $3.87M | $1.62M | $1.77M | $1.93M |
| Interest Expense | $2.90M | $1.75M | $1.75M | $1.78M | $910K | $1.15M | $867K | $883K |
| Income Before Tax | -$44.09M | $64.30M | -$24.26M | $56.78M | $141.1M | $11.22M | -$50.18M | -$39.20M |
| Income Tax Expense | -$15.61M | $15.80M | -$10.91M | $12.00M | $23.86M | $6.38M | -$7.73M | -$8.11M |
| **Net Income** | -$28.48M | $48.51M | -$13.35M | $44.78M | $117.3M | $4.85M | -$42.45M | -$31.09M |
| Basic EPS | -$1.43 | $2.42 | -$0.67 | -- | $5.99 | $0.25 | -$2.21 | -- |
| **Diluted EPS** | -$1.43 | $2.22 | -$0.67 | -- | $5.68 | $0.24 | -$2.21 | -- |
| Basic Shares Outstanding | 20.0M | 20.1M | 19.9M | -- | 19.6M | 19.3M | 19.2M | -- |
| Diluted Shares Outstanding | 20.0M | 21.8M | 19.9M | -- | 20.6M | 19.9M | 19.2M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $174.9M | $72.31M | $22.95M | $45.01M | $19.52M | $47.62M | $71.54M | $117.2M | $20.62M | $18.75M |
| Short-Term Investments | $558.6M | $183.9M | $147.4M | $166.9M | $321.6M | $363.6M | $998.3M | $601.2M | $181.0M | $122.3M |
| **Cash & Short-Term Investments** | $733.5M | $256.2M | $170.3M | $211.9M | $341.1M | $411.2M | $1.07B | $718.4M | $201.7M | $141.0M |
| Accounts Receivable, Net | $59.60M | $38.38M | $32.92M | $30.42M | $85.45M | $56.85M | $30.39M | $55.85M | $25.60M | $14.70M |
| Inventory | $9.13M | $14.11M | $23.97M | $13.29M | $27.33M | $26.49M | $7.30M | $7.12M | $4.37M | $1.92M |
| Other Current Assets | $5.79M | $8.81M | $2.66M | $2.27M | $3.57M | $3.82M | $4.73M | $11.02M | $1.51M | $2.17M |
| **Total Current Assets** | $832.3M | $331.6M | $237.4M | $263.6M | $464.8M | $500.6M | $1.12B | $870.5M | $237.0M | $163.1M |
| Property, Plant & Equipment, Net | $3.57M | $15.13M | $15.61M | $12.48M | $13.19M | $13.19M | $7.18M | $5.37M | $4.21M | $1.82M |
| Goodwill | $101.5M | $105.2M | $103.4M | $0 | $105.7M | $189.7M | $95.23M | $86.65M | $85.96M | $72.21M |
| Intangible Assets | $225.4M | $266.6M | $299.6M | $342.5M | $376.7M | $595.3M | $210.4M | $219.8M | $228.6M | $204.7M |
| Other Non-Current Assets | $12.58M | $31.73M | $6.39M | $1.74M | $1.25M | $4.27M | $2.27M | $471K | $4.86M | $1.74M |
| **Total Non-Current Assets** | $728.4M | $610.2M | $549.8M | $499.1M | $832.8M | $861.7M | $371.3M | $390.3M | $434.0M | $438.5M |
| **Total Assets** | $1.56B | $941.8M | $787.2M | $762.7M | $1.30B | $1.36B | $1.49B | $1.26B | $671.0M | $601.6M |
| Accounts Payable | $3.24M | $5.23M | $2.43M | $5.31M | $8.40M | $3.78M | $2.42M | $4.18M | $2.26M | $2.73M |
| Deferred Revenue (Current) | $621K | $621K | $1.22M | $355K | $654K | $29.43M | $2.14M | $3.29M | $0 | $0 |
| Other Current Liabilities | $135K | $1.30M | -- | $457K | -- | -- | -- | -- | -- | -- |
| **Total Current Liabilities** | $37.45M | $37.11M | $16.78M | $98.81M | $41.66M | $100.1M | $17.00M | $82.25M | $238.9M | $227.1M |
| Deferred Revenue (Non-Current) | $0 | $15.94M | $13.70M | $0 | $9.27M | -- | -- | -- | $3.52M | -- |
| Other Non-Current Liabilities | $16.63M | $30.16M | $27.76M | $27.76M | $21.75M | $30.87M | $22.48M | $951K | $4.25M | $687K |
| **Total Non-Current Liabilities** | $506.0M | $74.22M | $69.52M | $66.37M | $434.8M | $552.6M | $710.7M | $617.6M | $13.51M | $3.60M |
| **Total Liabilities** | $543.4M | $111.3M | $86.30M | $165.2M | $476.4M | $652.8M | $727.7M | $699.9M | $252.4M | $230.7M |
| **Total Debt (incl. Leases)** | $5.35M | $7.15M | $6.18M | $11.06M | $17.65M | $14.23M | $11.30M | -- | -- | -- |
| Common Stock | $20K | $20K | $18K | $17K | $17K | $16K | $17K | $21K | $21K | $21K |
| Retained Earnings | $608.1M | $499.0M | $503.0M | $450.9M | $449.1M | $392.0M | $400.1M | -$229.2M | -$400.9M | -$431.1M |
| Accumulated Other Comp. Income | $8.46M | -$5.94M | -$817K | -$984K | -$917K | -$801K | -$216K | -$1.02M | $2.49M | $2.74M |
| **Total Stockholders' Equity** | $1.02B | $830.4M | $700.9M | $597.5M | $821.2M | $709.5M | $767.2M | $560.9M | $399.8M | $341.3M |
| Total Equity | $1.02B | $830.4M | $700.9M | $597.5M | $821.2M | $709.5M | $767.2M | $560.9M | $399.8M | $341.3M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $55.96M | $1.01B | $115.1M | $174.9M | $139.4M | $67.67M | $47.99M | $72.31M |
| Short-Term Investments | $391.4M | $351.1M | $664.3M | $558.6M | $525.1M | $177.4M | $160.9M | $183.9M |
| **Cash & Short-Term Investments** | $447.4M | $1.36B | $779.4M | $733.5M | $664.5M | $245.0M | $208.9M | $256.2M |
| Accounts Receivable, Net | $83.22M | $67.01M | $53.38M | $59.60M | $57.56M | $41.29M | $38.49M | $38.38M |
| Inventory | $14.51M | $10.26M | $13.27M | $9.13M | $11.90M | $15.49M | $14.61M | $14.11M |
| Other Current Assets | $7.21M | $6.19M | $5.79M | $5.79M | $6.99M | $4.82M | $13.29M | $8.81M |
| **Total Current Assets** | $608.2M | $1.46B | $865.4M | $832.3M | $753.9M | $352.9M | $309.3M | $331.6M |
| Property, Plant & Equipment, Net | $3.71M | $3.40M | $3.44M | $3.57M | $3.47M | $3.63M | $3.62M | $15.13M |
| Goodwill | $207.9M | $101.5M | $101.5M | $101.5M | $101.5M | $101.5M | $101.5M | $105.2M |
| Intangible Assets | $302.0M | $209.2M | $217.3M | $225.4M | $233.5M | $250.1M | $258.4M | $266.6M |
| Other Non-Current Assets | $27.14M | $11.84M | $12.99M | $12.58M | $2.77M | $9.11M | $7.89M | $31.73M |
| **Total Non-Current Assets** | $1.63B | $728.8M | $666.7M | $728.4M | $722.9M | $595.7M | $596.1M | $610.2M |
| **Total Assets** | $2.24B | $2.19B | $1.53B | $1.56B | $1.48B | $948.6M | $905.4M | $941.8M |
| Accounts Payable | $4.09M | $9.40M | $5.26M | $3.24M | $3.68M | $8.58M | $5.37M | $5.23M |
| Short-Term Debt | $448.3M | -- | -- | -- | -- | -- | -- | -- |
| Deferred Revenue (Current) | $621K | $621K | $621K | $621K | $621K | $111K | $101K | $621K |
| Other Current Liabilities | $403K | $955K | $300K | $135K | $135K | -- | -- | $1.30M |
| **Total Current Liabilities** | $500.6M | $46.74M | $40.67M | $37.45M | $30.54M | $64.73M | $58.68M | $37.11M |
| Long-Term Debt | $679.9M | $1.13B | -- | -- | -- | -- | -- | -- |
| Deferred Revenue (Non-Current) | -- | -- | -- | $0 | $0 | $0 | $0 | $15.94M |
| Other Non-Current Liabilities | $17.32M | $17.22M | $17.11M | $16.63M | $19.91M | $14.37M | $14.25M | $30.16M |
| **Total Non-Current Liabilities** | $775.1M | $1.17B | $494.1M | $506.0M | $496.1M | $55.34M | $51.22M | $74.22M |
| **Total Liabilities** | $1.28B | $1.22B | $534.8M | $543.4M | $526.6M | $120.1M | $109.9M | $111.3M |
| **Total Debt (incl. Leases)** | $1.15B | $1.13B | $5.08M | $5.35M | $5.50M | $5.74M | $4.45M | $7.15M |
| Common Stock | $20K | $20K | $20K | $20K | $20K | $20K | $20K | $20K |
| Retained Earnings | $554.8M | $583.3M | $594.7M | $608.1M | $578.2M | $461.4M | $456.5M | $499.0M |
| Accumulated Other Comp. Income | $3.44M | $4.48M | $5.39M | $8.46M | $9.32M | $8.49M | -$1.56M | -$5.94M |
| **Total Stockholders' Equity** | $961.8M | $967.5M | $997.3M | $1.02B | $950.2M | $827.3M | $795.6M | $830.4M |
| Total Equity | $961.8M | $967.5M | $997.3M | $1.02B | $950.2M | $827.3M | $795.6M | $830.4M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | $124.5M | -$4.03M | $52.15M | -$33.36M | $57.14M | -$2.98M | $629.3M | $143.3M | $12.56M | -$1.64M |
| Depreciation & Amortization | $33.77M | $35.24M | $36.52M | $51.53M | $51.07M | $25.69M | $18.36M | $12.78M | $10.96M | $11.29M |
| Stock-Based Compensation | $46.85M | $41.09M | $25.74M | $60.28M | $38.78M | $30.73M | $24.52M | $20.85M | $24.91M | $18.89M |
| Change in Receivables | -$21.74M | -$6.46M | -$2.60M | $55.32M | -$28.62M | -$26.06M | $25.46M | -$29.54M | -$8.36M | -$8.53M |
| Change in Inventory | $4.99M | $9.62M | -$10.87M | $12.06M | -$427K | -$17.80M | -$2.06M | -$2.56M | -$843K | -$244K |
| **Operating Cash Flow** | $49.36M | $97.05M | $49.58M | $137.8M | $78.80M | $54.59M | -$29.34M | $194.1M | $88.57M | $60.73M |
| Capital Expenditure | -$452K | -$1.82M | -$3.52M | -$17.92M | -$8.76M | -$4.46M | -$2.55M | -$887K | -$2.16M | -$1.85M |
| **Free Cash Flow** | $48.91M | $95.23M | $46.06M | $119.9M | $70.04M | $50.13M | -$31.89M | $193.2M | $86.41M | $58.88M |
| Acquisitions, Net | $0 | $0 | -$10.40M | $0 | $0 | -$404.9M | -$11.84M | -$5.86M | -$26.65M | -$92.50M |
| **Investing Cash Flow** | -$377.3M | -$143.7M | -$11.68M | $163.6M | $30.52M | $231.6M | $466.9M | -$423.3M | -$79.18M | -$134.4M |
| Common Stock Issued | $0 | $37.14M | $0 | $0 | -- | -- | -- | -- | -- | -- |
| Share Repurchases | -$15.00M | $0 | $0 | $0 | $0 | -$78.00M | -$453.0M | -$122.9M | -$1.97M | -$3.90M |
| **Financing Cash Flow** | $428.2M | $97.14M | -$59.95M | -$276.0M | -$137.8M | -$310.5M | -$485.2M | $328.6M | -$7.52M | -$4.99M |
| **Net Change in Cash** | $102.6M | $49.35M | -$22.05M | $25.48M | -$28.44M | -$24.31M | -$47.59M | $99.38M | $1.87M | -$78.68M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$28.48M | $48.51M | -$13.35M | $44.78M | $117.3M | $4.85M | -$42.45M | -$31.09M |
| Depreciation & Amortization | $10.32M | $8.21M | $8.22M | $8.21M | $8.27M | $8.52M | $8.77M | $8.63M |
| Stock-Based Compensation | $18.18M | $13.65M | $10.60M | $14.27M | $14.75M | $10.00M | $7.84M | $7.52M |
| Change in Receivables | -$16.27M | -$13.85M | $6.41M | -$2.09M | -$16.31M | -$2.77M | -$576K | -$5.67M |
| Change in Inventory | -$4.25M | $3.00M | -$4.14M | $2.77M | $3.59M | -$875K | -$500K | $2.57M |
| **Operating Cash Flow** | -$27.59M | $24.02M | $48.69M | $45.91M | $13.09M | $15.80M | -$25.45M | $28.47M |
| Capital Expenditure | -$142K | -$26K | -$228K | -$9.0K | -$15K | -$214K | -$214K | -$712K |
| **Free Cash Flow** | -$27.73M | $23.99M | $48.46M | $45.91M | $13.07M | $15.59M | -$25.66M | $27.76M |
| **Investing Cash Flow** | -$878.0M | $321.1M | -$94.35M | -$18.10M | -$353.4M | -$10.67M | $4.89M | -$38.62M |
| **Financing Cash Flow** | $4.06M | $546.4M | -$14.13M | $8.33M | $409.6M | $14.99M | -$4.75M | $20.39M |
| **Net Change in Cash** | -$903.3M | $891.6M | -$59.83M | $35.55M | $71.71M | $19.68M | -$24.32M | $8.69M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | -- | -- | -- | -- | -- | -- | -- | 97.5% | 96.2% | 94.9% |
| **Operating Margin** | 15.3% | -13.5% | 9.1% | 1.5% | 43.0% | 22.9% | 671.0% | 65.1% | 48.2% | 40.3% |
| **Net Profit Margin** | 46.4% | -2.4% | 39.7% | -17.0% | 23.7% | -1.8% | 523.2% | 57.0% | 8.9% | -1.5% |
| Return on Equity (ROE) | 12.2% | -0.5% | 7.4% | -5.6% | 7.0% | -0.4% | 82.0% | 25.6% | 3.1% | -0.5% |
| Return on Assets (ROA) | 8.0% | -0.4% | 6.6% | -4.4% | 4.4% | -0.2% | 42.1% | 11.4% | 1.9% | -0.3% |
| Current Ratio | 22.23x | 8.93x | 14.15x | 2.67x | 11.15x | 5.00x | 66.09x | 10.58x | 0.99x | 0.72x |
| Quick Ratio | 21.98x | 8.55x | 12.72x | 2.53x | 10.50x | 4.74x | 65.66x | 10.50x | 0.97x | 0.71x |
| Debt to Equity | 0.01x | 0.01x | 0.01x | 0.02x | 0.02x | 0.02x | 0.01x | -- | -- | -- |
| **Revenue Growth (YoY)** | +60.4% | +27.3% | -33.1% | -18.8% | +47.7% | +36.0% | -52.2% | +78.2% | +29.5% | +51.5% |
| Gross Profit Growth (YoY) | -- | -- | -- | -- | -- | -- | -- | +80.6% | +31.3% | +56.4% |
| Operating Income Growth (YoY) | -- | -289.3% | +293.2% | -97.1% | +176.9% | -95.4% | +392.9% | +140.5% | +55.1% | +60.6% |
| **Net Income Growth (YoY)** | -- | -107.7% | -- | -158.4% | -- | -100.5% | +339.1% | +1041.5% | -- | -100.7% |
| EPS Growth (YoY) | -- | -107.3% | -- | -157.6% | -- | -100.5% | +389.4% | +1028.3% | -- | -100.7% |
| Operating Cash Flow Growth (YoY) | -49.1% | +95.8% | -64.0% | +74.9% | +44.4% | -- | -115.1% | +119.1% | +45.8% | +45.5% |
| Free Cash Flow Growth (YoY) | -48.6% | +106.8% | -61.6% | +71.2% | +39.7% | -- | -116.5% | +123.5% | +46.8% | +41.4% |
| 5Y Revenue / Share Growth | +37.2% | +44.3% | -36.1% | +73.4% | +177.6% | +178.1% | +100.3% | +392.9% | +324.3% | +242.3% |
| 10Y Revenue / Share Growth | +281.5% | +189.1% | +214.9% | +635.9% | +850.5% | +40.4% | -48.9% | -- | -- | -- |
| 5Y Net Income / Share Growth | -- | -100.7% | -55.5% | -431.3% | -- | -101.6% | +5526.1% | +1104.7% | -- | -115.9% |
| 10Y Net Income / Share Growth | -44.6% | -137.4% | +436.3% | -- | +595.1% | -- | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | 10.1% | 33.3% | 35.2% | 16.0% | 7.2% | -18.3% | -34.1% | -13.5% |
| **Net Profit Margin** | 20.3% | 67.9% | 55.9% | 46.4% | 19.3% | -40.4% | -73.1% | -2.4% |
| Return on Equity (ROE) | 5.4% | 20.4% | 15.4% | 12.2% | 5.1% | -9.2% | -16.7% | -0.5% |
| Return on Assets (ROA) | 2.3% | 9.0% | 10.0% | 8.0% | 3.3% | -8.0% | -14.6% | -0.4% |
| Current Ratio | 1.22x | 31.18x | 21.28x | 22.23x | 24.69x | 5.45x | 5.27x | 8.93x |
| Quick Ratio | 1.19x | 30.96x | 20.95x | 21.98x | 24.30x | 5.21x | 5.02x | 8.55x |
| Debt to Equity | 1.20x | 1.17x | 0.01x | 0.01x | 0.01x | 0.01x | 0.01x | 0.01x |
| **Revenue Growth (YoY)** | -31.8% | +33.7% | +14.1% | +39.4% | +122.8% | +14.7% | +46.3% | +52.4% |
| Operating Income Growth (YoY) | -128.5% | +1.7% | -- | -- | +1662.2% | -- | -1312.0% | -- |
| **Net Income Growth (YoY)** | -124.3% | +900.8% | -- | -- | -- | -- | -149.3% | -270.9% |
| EPS Growth (YoY) | -123.9% | +868.0% | -- | -- | -- | -- | -145.5% | -- |
| Operating Cash Flow Growth (YoY) | -310.8% | +52.0% | -- | +61.3% | -64.2% | +18.7% | -235.8% | +253.0% |
| Free Cash Flow Growth (YoY) | -312.1% | +53.9% | -- | +65.4% | -63.6% | +20.8% | -237.8% | +263.0% |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
